Soteropoulos Paula
Insider CIK 1692444 · QURE Director · AKCA President & CEO, Director · DNTH Director · RLYB Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RLYB Rallybio Corp | M Exercise deriv | 2026-10-16 | 2026-10-20 | 3,562 | — | $0 | 0 | SEC↗ |
| RLYB Rallybio Corp | M Exercise | 2026-10-16 | 2026-10-20 | 3,562 | $2.38 | $8.5K | 6,544 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | A Award deriv | 2026-05-21 | 2026-05-22 | 6,090 | — | $0 | 6,090 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | M Exercise deriv | 2026-05-08 | 2026-05-11 | 599 | — | $0 | 0 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | S Sale | 2026-05-08 | 2026-05-11 | 599 | $85.47 | $51.2K | 0 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | M Exercise | 2026-05-08 | 2026-05-11 | 599 | $8.44 | $5.1K | 599 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | M Exercise deriv | 2026-03-31 | 2026-04-01 | 599 | — | $0 | 599 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | S Sale | 2026-03-31 | 2026-04-01 | 599 | $80.11 | $48.0K | 0 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | M Exercise | 2026-03-31 | 2026-04-01 | 599 | $8.44 | $5.1K | 599 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | M Exercise deriv | 2026-03-24 | 2026-03-26 | 27,594 | — | $0 | 1,198 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | M Exercise | 2026-03-24 | 2026-03-26 | 27,594 | $8.44 | $232.9K | 27,594 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | S Sale | 2026-03-24 | 2026-03-26 | 27,594 | $78.05 | $2.15M | 0 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | A Award deriv | 2025-05-22 | 2025-05-22 | 12,500 | — | $0 | 12,500 | SEC↗ |
| RLYB Rallybio Corp | A Award deriv | 2025-05-13 | 2025-05-15 | 28,500 | — | $0 | 28,500 | SEC↗ |
| QURE uniQure N.V. | S Sale | 2024-06-13 | 2024-06-17 | 2,220 | $5.14 | $11.4K | 20,203 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | A Award deriv | 2024-05-23 | 2024-05-28 | 11,000 | — | $0 | 11,000 | SEC↗ |
| RLYB Rallybio Corp | A Award deriv | 2024-05-15 | 2024-05-17 | 16,500 | — | $0 | 16,500 | SEC↗ |
| DNTH Dianthus Therapeutics, Inc | A Award deriv | 2023-09-11 | 2023-09-13 | 6,500 | — | $0 | 6,500 | SEC↗ |
| QURE uniQure N.V. | S Sale | 2023-06-16 | 2023-06-20 | 2,275 | $18.99 | $43.2K | 22,423 | SEC↗ |
| QURE uniQure N.V. | A Award deriv | 2023-06-13 | 2023-06-20 | 17,060 | — | $0 | 17,060 | SEC↗ |
| QURE uniQure N.V. | A Award | 2023-06-13 | 2023-06-20 | 8,700 | — | $0 | 24,698 | SEC↗ |
| RLYB Rallybio Corp | A Award deriv | 2023-05-17 | 2023-05-19 | 15,490 | — | $0 | 15,490 | SEC↗ |
| QURE uniQure N.V. | S Sale | 2023-02-27 | 2023-03-01 | 384 | $19.97 | $7.7K | 15,998 | SEC↗ |
| QURE uniQure N.V. | M Exercise deriv | 2023-01-18 | 2023-01-20 | 6,000 | — | $0 | 2,000 | SEC↗ |
| QURE uniQure N.V. | S Sale | 2023-01-18 | 2023-01-20 | 6,000 | $22.59 | $135.5K | 16,382 | SEC↗ |
| QURE uniQure N.V. | M Exercise | 2023-01-18 | 2023-01-20 | 6,000 | $5.37 | $32.2K | 22,382 | SEC↗ |
| QURE uniQure N.V. | M Exercise deriv | 2022-12-14 | 2022-12-15 | 3,800 | — | $0 | 0 | SEC↗ |
| QURE uniQure N.V. | M Exercise | 2022-12-14 | 2022-12-15 | 3,800 | — | $0 | 20,182 | SEC↗ |
| QURE uniQure N.V. | S Sale | 2022-12-14 | 2022-12-15 | 3,800 | $23.43 | $89.0K | 16,382 | SEC↗ |
| QURE uniQure N.V. | M Exercise deriv | 2022-12-13 | 2022-12-15 | 3,000 | — | $0 | 8,000 | SEC↗ |
| QURE uniQure N.V. | S Sale | 2022-12-13 | 2022-12-15 | 3,000 | $23.45 | $70.3K | 16,382 | SEC↗ |
| QURE uniQure N.V. | M Exercise | 2022-12-13 | 2022-12-15 | 3,000 | $5.37 | $16.1K | 19,382 | SEC↗ |
| QURE uniQure N.V. | M Exercise deriv | 2022-11-29 | 2022-12-01 | 6,200 | — | $0 | 3,800 | SEC↗ |
| QURE uniQure N.V. | S Sale | 2022-11-29 | 2022-12-01 | 6,200 | $25.38 | $157.4K | 16,382 | SEC↗ |
| QURE uniQure N.V. | M Exercise | 2022-11-29 | 2022-12-01 | 6,200 | — | $0 | 22,582 | SEC↗ |
| QURE uniQure N.V. | A Award deriv | 2022-06-15 | 2022-06-17 | 17,810 | — | $0 | 17,810 | SEC↗ |
| QURE uniQure N.V. | A Award | 2022-06-15 | 2022-06-17 | 9,080 | — | $0 | 16,382 | SEC↗ |
| RLYB Rallybio Corp | A Award deriv | 2022-05-24 | 2022-05-26 | 13,440 | — | $0 | 13,440 | SEC↗ |
| QURE uniQure N.V. | S Sale | 2022-02-28 | 2022-03-02 | 596 | $16.87 | $10.1K | 7,302 | SEC↗ |
| QURE uniQure N.V. | A Award deriv | 2022-02-24 | 2022-02-28 | 2,645 | — | $0 | 2,645 | SEC↗ |
| QURE uniQure N.V. | A Award | 2022-02-24 | 2022-02-28 | 1,534 | — | $0 | 7,898 | SEC↗ |
| RLYB Rallybio Corp | A Award deriv | 2022-01-03 | 2022-01-05 | 5,369 | — | $0 | 5,369 | SEC↗ |
| QURE uniQure N.V. | S Sale | 2021-03-02 | 2021-03-04 | 504 | $37.60 | $19.0K | 6,364 | SEC↗ |
| QURE uniQure N.V. | A Award deriv | 2021-02-25 | 2021-03-01 | 4,107 | — | $0 | 4,107 | SEC↗ |
| QURE uniQure N.V. | A Award | 2021-02-25 | 2021-03-01 | 2,382 | — | $0 | 6,868 | SEC↗ |
| QURE uniQure N.V. | A Award deriv | 2020-02-27 | 2020-03-02 | 3,620 | — | $0 | 3,620 | SEC↗ |
| QURE uniQure N.V. | A Award | 2020-02-27 | 2020-03-02 | 2,063 | — | $0 | 4,486 | SEC↗ |
| QURE uniQure N.V. | S Sale | 2020-02-05 | 2020-02-05 | 1,300 | $60.58 | $78.8K | 3,245 | SEC↗ |
| QURE uniQure N.V. | S Sale | 2020-02-05 | 2020-02-05 | 822 | $61.53 | $50.6K | 2,423 | SEC↗ |
| QURE uniQure N.V. | S Sale | 2020-01-28 | 2020-01-30 | 807 | $62.19 | $50.2K | 4,545 | SEC↗ |
| QURE uniQure N.V. | S Sale | 2020-01-07 | 2020-01-08 | 3,000 | $72.18 | $216.5K | 5,352 | SEC↗ |
| QURE uniQure N.V. | M Exercise deriv | 2019-12-13 | 2019-12-17 | 2,000 | — | $0 | 9,000 | SEC↗ |
| QURE uniQure N.V. | M Exercise | 2019-12-13 | 2019-12-17 | 2,000 | $5.37 | $10.7K | 10,352 | SEC↗ |
| QURE uniQure N.V. | S Sale | 2019-12-13 | 2019-12-17 | 2,000 | $70.50 | $141.0K | 8,352 | SEC↗ |
| QURE uniQure N.V. | S Sale | 2019-12-09 | 2019-12-09 | 2,500 | $67.50 | $168.8K | 8,352 | SEC↗ |
| QURE uniQure N.V. | S Sale | 2019-12-06 | 2019-12-09 | 7,382 | $64.39 | $475.3K | 10,852 | SEC↗ |
| QURE uniQure N.V. | S Sale | 2019-12-06 | 2019-12-09 | 1,700 | $63.69 | $108.3K | 18,234 | SEC↗ |
| AKCA AKCEA THERAPEUTICS, INC. | M Exercise deriv | 2019-09-26 | 2019-09-30 | 1,711,079 | — | $0 | 0 | SEC↗ |
| AKCA AKCEA THERAPEUTICS, INC. | M Exercise deriv | 2019-09-26 | 2019-09-30 | 145,303 | — | $0 | 13,209 | SEC↗ |
| AKCA AKCEA THERAPEUTICS, INC. | M Exercise deriv | 2019-09-26 | 2019-09-30 | 205,479 | — | $0 | 102,740 | SEC↗ |
| AKCA AKCEA THERAPEUTICS, INC. | F Tax w/h | 2019-09-26 | 2019-09-30 | 1,113,492 | $16.64 | $18.53M | 597,587 | SEC↗ |
| AKCA AKCEA THERAPEUTICS, INC. | F Tax w/h | 2019-09-26 | 2019-09-30 | 175,064 | $16.64 | $2.91M | 678,149 | SEC↗ |
| AKCA AKCEA THERAPEUTICS, INC. | M Exercise | 2019-09-26 | 2019-09-30 | 205,479 | $12.21 | $2.51M | 853,213 | SEC↗ |
| AKCA AKCEA THERAPEUTICS, INC. | F Tax w/h | 2019-09-26 | 2019-09-30 | 95,156 | $16.64 | $1.58M | 647,734 | SEC↗ |
| AKCA AKCEA THERAPEUTICS, INC. | M Exercise | 2019-09-26 | 2019-09-30 | 145,303 | $6.48 | $941.6K | 742,890 | SEC↗ |
| AKCA AKCEA THERAPEUTICS, INC. | M Exercise | 2019-09-26 | 2019-09-30 | 1,711,079 | $6.48 | $11.09M | 1,711,079 | SEC↗ |
| AKCA AKCEA THERAPEUTICS, INC. | M Exercise deriv | 2019-04-08 | 2019-04-09 | 1,787 | — | $0 | 1,711,079 | SEC↗ |
| AKCA AKCEA THERAPEUTICS, INC. | M Exercise | 2019-04-08 | 2019-04-09 | 1,787 | $6.48 | $11.6K | 1,787 | SEC↗ |
| AKCA AKCEA THERAPEUTICS, INC. | S Sale | 2019-04-08 | 2019-04-09 | 1,787 | $32.17 | $57.5K | 0 | SEC↗ |
| AKCA AKCEA THERAPEUTICS, INC. | M Exercise deriv | 2019-04-05 | 2019-04-09 | 30,000 | — | $0 | 1,712,866 | SEC↗ |
| AKCA AKCEA THERAPEUTICS, INC. | M Exercise | 2019-04-05 | 2019-04-09 | 30,000 | $6.48 | $194.4K | 30,000 | SEC↗ |
| AKCA AKCEA THERAPEUTICS, INC. | S Sale | 2019-04-05 | 2019-04-09 | 30,000 | $32.11 | $963.3K | 0 | SEC↗ |
| AKCA AKCEA THERAPEUTICS, INC. | M Exercise deriv | 2019-03-06 | 2019-03-07 | 18,386 | — | $0 | 1,742,866 | SEC↗ |
| AKCA AKCEA THERAPEUTICS, INC. | M Exercise | 2019-03-06 | 2019-03-07 | 18,386 | $6.48 | $119.1K | 18,386 | SEC↗ |
| AKCA AKCEA THERAPEUTICS, INC. | S Sale | 2019-03-06 | 2019-03-07 | 18,386 | $32.14 | $590.9K | 0 | SEC↗ |
| QURE uniQure N.V. | S Sale | 2019-01-28 | 2019-01-30 | 1,210 | $31.32 | $37.9K | 19,934 | SEC↗ |
| QURE uniQure N.V. | A Award deriv | 2019-01-25 | 2019-01-29 | 5,295 | — | $0 | 5,295 | SEC↗ |
| QURE uniQure N.V. | A Award | 2019-01-25 | 2019-01-29 | 3,230 | — | $0 | 21,144 | SEC↗ |
| AKCA AKCEA THERAPEUTICS, INC. | A Award deriv | 2019-01-02 | 2019-01-04 | 296,000 | — | $0 | 296,000 | SEC↗ |
| QURE uniQure N.V. | S Sale | 2018-01-29 | 2018-01-31 | 2,878 | $18.53 | $53.3K | 17,914 | SEC↗ |
| QURE uniQure N.V. | A Award deriv | 2018-01-26 | 2018-01-30 | 6,390 | — | $0 | 6,390 | SEC↗ |
| QURE uniQure N.V. | A Award | 2018-01-26 | 2018-01-30 | 4,792 | — | $0 | 20,792 | SEC↗ |
| AKCA AKCEA THERAPEUTICS, INC. | A Award deriv | 2018-01-02 | 2018-01-04 | 275,000 | — | $0 | 275,000 | SEC↗ |
| QURE uniQure N.V. | A Award deriv | 2017-01-27 | 2017-01-31 | 11,000 | — | $0 | 16,000 | SEC↗ |
| QURE uniQure N.V. | A Award deriv | 2017-01-27 | 2017-01-31 | 11,000 | — | $0 | 11,000 | SEC↗ |